American Equity Investment Life (AEL) Stock Forecast, Price & News

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for American Equity Investment Life in the last year. There are currently 7 hold ratings, 2 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" AEL shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in AEL, but not buy additional shares or sell existing shares.
View AEL analyst ratings or view top-rated stocks.

10 Wall Street research analysts have issued 1-year price targets for American Equity Investment Life's stock. Their AEL share price forecasts range from $38.00 to $51.00. On average, they predict the company's stock price to reach $44.90 in the next twelve months. This suggests a possible upside of 10.3% from the stock's current price.
View analysts price targets for AEL or view top-rated stocks among Wall Street analysts.

American Equity Investment Life's stock was trading at $45.62 at the beginning of 2023. Since then, AEL shares have decreased by 10.8% and is now trading at $40.69.
View the best growth stocks for 2023 here.

American Equity Investment Life saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 3,860,000 shares, a decrease of 8.1% from the April 30th total of 4,200,000 shares. Based on an average trading volume of 661,900 shares, the short-interest ratio is presently 5.8 days. Approximately 4.7% of the shares of the stock are short sold.
View American Equity Investment Life's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 14th 2023.
View our AEL earnings forecast.

American Equity Investment Life Holding (NYSE:AEL) announced its quarterly earnings results on Tuesday, May, 9th. The financial services provider reported $1.47 EPS for the quarter, topping analysts' consensus estimates of $1.15 by $0.32. The financial services provider had revenue of $662.50 million for the quarter, compared to analysts' expectations of $626.02 million. American Equity Investment Life had a trailing twelve-month return on equity of 12.84% and a net margin of 25.84%. American Equity Investment Life's revenue for the quarter was up 348.2% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.92 earnings per share.

American Equity Investment Life declared an annual dividend on Thursday, November 17th. Investors of record on Monday, November 28th will be paid a dividend of $0.02 per share on Tuesday, December 13th. This represents a yield of 0.05%. The ex-dividend date is Friday, November 25th.
Read our dividend analysis for AEL.

ETFs with the largest weight of American Equity Investment Life (NYSE:AEL) stock in their portfolio include The Acquirers Fund (ZIG), SPDR S&P Insurance ETF (KIE), Invesco S&P SmallCap Quality ETF (XSHQ), Cambria Value and Momentum ETF (VAMO), Invesco S&P SmallCap Financials ETF (PSCF), Invesco S&P SmallCap Value with Momentum ETF (XSVM), Royce Quant Small-Cap Quality Value ETF (SQLV) and Invesco Raymond James SB-1 Equity ETF (RYJ).

American Equity Investment Life (NYSE:AEL) pays an annual dividend of $0.02 per share and currently has a dividend yield of 0.05%. The company has been increasing its dividend for 18 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 0.42%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, AEL will have a dividend payout ratio of 0.31% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for AEL.

2 employees have rated American Equity Investment Life Chief Executive Officer Anant Bhalla on Glassdoor.com. Anant Bhalla has an approval rating of 100% among the company's employees. This puts Anant Bhalla in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other American Equity Investment Life investors own include Energy Transfer (ET), Extreme Networks (EXTR), Neos Therapeutics (NEOS), Neurotrope (NTRP), Pfizer (PFE), Activision Blizzard (ATVI), Bank of America (BAC), Chimerix (CMRX), Lam Research (LRCX) and Nasdaq (NDAQ).

American Equity Investment Life trades on the New York Stock Exchange (NYSE) under the ticker symbol "AEL."

American Equity Investment Life's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (14.53%), Dimensional Fund Advisors LP (8.62%), State Street Corp (3.74%), Clearbridge Investments LLC (3.14%), Macquarie Group Ltd. (2.75%) and Macquarie Group Ltd. (2.74%). Insiders that own company stock include Alan David Matula, Anant Bhalla, David S Mulcahy, Gerard D Neugent, Jeffrey D Lorenzen, John M Matovina, Joyce Ann Chapman, Robert L Howe, Ronald James Grensteiner and Ted Morris Johnson.
View institutional ownership trends.

Shares of AEL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of AEL stock can currently be purchased for approximately $40.69.

American Equity Investment Life (NYSE:AEL) has a market capitalization of $3.17 billion and generates $1.42 billion in revenue each year. The financial services provider earns $1.22 billion in net income (profit) each year or $4.81 on an earnings per share basis.

The company employs 800 workers across the globe.

American Equity Investment Life's mailing address is 6000 Westown Parkway, West Des Moines IA, 50266. The official website for the company is www.american-equity.com. The financial services provider can be reached via phone at (515) 221-0002, via email at sschwartz@american-equity.com, or via fax at 515-221-9947.